| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/24/2005 | WO2004069849A3 Bead emulsion nucleic acid amplification |
| 03/24/2005 | WO2004069175A3 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES |
| 03/24/2005 | WO2004068107A3 Apparatus and method for transcellular testing |
| 03/24/2005 | WO2004067554A3 Compositions and methods of tolerizing a primate to an antigen |
| 03/24/2005 | WO2004065592A3 The crystal structure of a catalytically active portion of a set 7/9 histone methyltransferase and uses thereof |
| 03/24/2005 | WO2004060925A3 Multiplex polymer ligation |
| 03/24/2005 | WO2004056309A3 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 03/24/2005 | WO2004048546A3 Methods for identifying risk of breast cancer and treatments thereof |
| 03/24/2005 | WO2004047746A3 Regulation of stearoyl-coa desaturase to treat obesity |
| 03/24/2005 | WO2004047731A3 Modulation of notch3 expression |
| 03/24/2005 | WO2004043979A3 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 03/24/2005 | WO2004041177A3 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 03/24/2005 | WO2004036183A3 Analyte sensors and methods for making them |
| 03/24/2005 | WO2004034032A3 Sliver type autonomous biosensors |
| 03/24/2005 | WO2004034025A3 Nano-chem-fet based biosensors |
| 03/24/2005 | WO2004029225A3 Detection of modular polyketide synthase gene clusters |
| 03/24/2005 | WO2004020661A3 Test system for the discovery of active agents in nerve cell diseases |
| 03/24/2005 | WO2004016767A3 Evolving new molecular function |
| 03/24/2005 | WO2004016228A3 HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS |
| 03/24/2005 | WO2004012683A9 Novel druggable regions in set domain proteins and methods of using the same |
| 03/24/2005 | WO2003106637A3 Polymeric label molecules |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 03/24/2005 | WO2003094856A3 1l1rl-1 as a cardiovascular disease marker and therapeutic target |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2003074548A8 Phage ligand sensor devices and uses thereof |
| 03/24/2005 | WO2003072746A3 Subtilisin carlsberg proteins with reduced immunogenicity |
| 03/24/2005 | WO2003060151A3 Novel calpastatin (cast) alleles |
| 03/24/2005 | WO2003048786A3 Pipette configurations and arrays thereof for measuring cellular electrical properties |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | WO2002058450A3 Regulation of cell growth by muc1 |
| 03/24/2005 | WO2001068858A8 Human g protein-coupled receptors |
| 03/24/2005 | US20050066380 Perv screening method and use thereof |
| 03/24/2005 | US20050066378 Transgenic animal comprising gene which induces lymphoproliferation for use as tool in generating autoantibodies for detection and treatment of autoimmune diseases; immunotherapy |
| 03/24/2005 | US20050066376 Genetic manipulation method |
| 03/24/2005 | US20050065737 genotypically and phenotypically characterizing a sample of a population |
| 03/24/2005 | US20050065736 Systems and methods for improving efficiencies in livestock production |
| 03/24/2005 | US20050065330 Identification of Histoplasma capsulatum using a PCR assay |
| 03/24/2005 | US20050065171 Therapy, prevention leukemia; antitumor agents |
| 03/24/2005 | US20050065092 Method of treating obesity and metabolic disorders related to excess adipose tissue by administration of natriuretic peptide receptor C inhibitors |
| 03/24/2005 | US20050065076 Gamma three protease |
| 03/24/2005 | US20050064604 Assay based on doped nanoparticles |
| 03/24/2005 | US20050064598 Microfluidic differential extraction cartridge |
| 03/24/2005 | US20050064594 Transgenic liver cell for use as tool in diagnosis, prevention and treatment of viral diseases; viricides and receptor binding activity |
| 03/24/2005 | US20050064585 Apparatus comprising two endcapping sections and a hollow fibre filter for use in isolation and detection of microorganisms in fluids; hemodialysis membrane; calculating viral load |
| 03/24/2005 | US20050064583 Temperature controlled illuminator for treating biological samples |
| 03/24/2005 | US20050064582 Multicompartment apparatus comprising capillary tubing for use in amplification of nucleic acids |
| 03/24/2005 | US20050064572 Lipid kinase |
| 03/24/2005 | US20050064544 Nucleotide sequences coding kinase for use as tool in identifying modulator for treatment and prevention of respiratory, cell proliferative, prostate, mammary gland and muscle disorders |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064537 Molecular weight markers for western blot |
| 03/24/2005 | US20050064534 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 03/24/2005 | US20050064533 Asparagine hydroxylation of the cad domain of a hif protein |
| 03/24/2005 | US20050064532 Compounds for determining the activity of phospholipase a2? |
| 03/24/2005 | US20050064531 Methods for screening and identifying compounds |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064528 Non-or minimally invasive monitoring methods |
| 03/24/2005 | US20050064527 Identifying modulator of activity of newly identified multiple antibiotic resistance (mar) locus regulated (NIMR) gene products; microbiocides; bactericides |
| 03/24/2005 | US20050064524 Cell for use as tools in analyte detection; biosensor for screening quality of food and water |
| 03/24/2005 | US20050064523 Using endothelial growth factor receptor and slectin concentration as diagnostic indicator of a cells angiogenic status; for use in tissue growth, remodeling and wound healing |
| 03/24/2005 | US20050064522 EG-VEGF nucleic acids and polypeptides and methods of use |
| 03/24/2005 | US20050064510 Ligand analysis |
| 03/24/2005 | US20050064507 Determining kinase specificity |
| 03/24/2005 | US20050064500 Using reference database as tool in enhancing accuracy of genetic analysis of microsamples; bioinformatics |
| 03/24/2005 | US20050064498 High throughput screening for sequences of interest |
| 03/24/2005 | US20050064497 Using high density lipoprotein concentration as prognostic indicator of resistance to myocardial disease |
| 03/24/2005 | US20050064495 Genetic typing of the human cytochrome P450 2A6 gene and related methods |
| 03/24/2005 | US20050064494 Chemically modified biological molecules and methods for coupling biological molecules to solid support |
| 03/24/2005 | US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere |
| 03/24/2005 | US20050064490 Methods of synthesizing polynucleotides using thermostable enzymes |
| 03/24/2005 | US20050064488 Using sequence amplification or strand displacement to identify and propagate preferential nucleotide sequences; genomics and gene expression analysis |
| 03/24/2005 | US20050064487 Using solid support to amplify preferential nucleotide sequences; screening for genetic polymorphisms and aberrations |
| 03/24/2005 | US20050064486 Novel genome analyzing method |
| 03/24/2005 | US20050064485 antibodies, polypeptides, polynucleotides, lipids, polysaccharides or hormones; kits and analysis apparatus for detection of molecular interactions using fluorescence polarization and/or time-resolved fluorescence resonance energy transfer |
| 03/24/2005 | US20050064484 Method for design support of functional nucleic acids |
| 03/24/2005 | US20050064483 quantitative analysis of the expression profiles of genes selected based on their roles in inflammation and their sensitivty to regulation by current multiple sclerosis treatment agents, beta-interferon and glatiramer acetate; bioassays |
| 03/24/2005 | US20050064481 Method for reducing background contamination |
| 03/24/2005 | US20050064480 Nucleotide sequences coding formin-like 2 (FHOD-2) gene for use as diagnostic and therapeutic tool in detection and treatment of pancreatic disorders |
| 03/24/2005 | US20050064478 Universal nucleic acid amplification system for nucleic acids in a sample |
| 03/24/2005 | US20050064477 Using polypeptide comprising two Cys2His2 zinc fingers domains as tool in detecting DNA/protein interactions; bioassays |
| 03/24/2005 | US20050064476 Methods for identifying DNA copy number changes |
| 03/24/2005 | US20050064475 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 03/24/2005 | US20050064474 Cleaving cellular chromatin and inserting expression vector comprising nucleotide sequences coding zinc finger-cleavage half domain genetic exchange; genome engineering and homologous recombination |
| 03/24/2005 | US20050064473 Identifying preferential genetic loci comprising single nucleotide polymorphisms (SNP) via comparing heteroduplex and homoduplex peaks in denaturaion and renaturation analysis |
| 03/24/2005 | US20050064472 Methods of monitoring gene expression |
| 03/24/2005 | US20050064471 Probe design for the detection of RNAs in cell extracts, cells, and tissues |
| 03/24/2005 | US20050064470 High throughput screening methods for identifying RNA binding compounds |
| 03/24/2005 | US20050064469 Reaction vessel for carrying out array processes |
| 03/24/2005 | US20050064465 Using bioreactor comprising RNA polymerase, gene transcription mixture and immobilized templates to generate preferential RNA species; high throughput assay and genic analysis |
| 03/24/2005 | US20050064463 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 03/24/2005 | US20050064462 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms |
| 03/24/2005 | US20050064461 Determining a predisposition to cancer |
| 03/24/2005 | US20050064460 Emulsion compositions |
| 03/24/2005 | US20050064459 Ligation assay |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064457 Methods for incorporating non-perfectly matched oligonucleotides into target-specific hybridization sequences |
| 03/24/2005 | US20050064456 Preparing preferential nucleotide sequences comprising hybridizing first and second oligonucleotides to non-overlapping portions of target sequences, extending and attaching oligonucleotides using RNA primer, cleaving primer, recover sequences |
| 03/24/2005 | US20050064455 Gene expression markers for predicting response to chemotherapy |
| 03/24/2005 | US20050064454 Cancer gene determination and therapeutic screening using signature gene sets |
| 03/24/2005 | US20050064453 Kit which utilizes interleukin-1-related gene as diagnostic/prognostic tool in detection of urogenital disorders; genomics and bioinformatics |